These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3919550)

  • 21. Hemodynamic and coronary effects of molsidomine at basal state, during atrial pacing, and during cold pressor test in patients with stable angina pectoris.
    Juliard JM; Neukirch F; Zygelman M; Merillon JP; Michel PL; Pansard Y; Dahan M; Gourgon R
    Am Heart J; 1985 Mar; 109(3 Pt 2):662-6. PubMed ID: 3838404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the effects of molsidomine by cardiac equilibrium blood pool scintigraphy.
    Chevigné M; Rigo P; Kassab A; Kulbertus H
    Am Heart J; 1985 Mar; 109(3 Pt 2):658-61. PubMed ID: 3838403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemodynamic effects of molsidomine in chronic congestive heart failure].
    Humar F; Maras P; Musitelli G; Camerini F
    G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of catecholamines on cardiovascular actions of molsidomine in anesthetized dogs.
    Fiedler VB; Göbel H; Nitz RE
    J Cardiovasc Pharmacol; 1983; 5(3):491-8. PubMed ID: 6191151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 28. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
    Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
    Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo.
    Messin R
    Am Heart J; 1985 Mar; 109(3 Pt 2):667-9. PubMed ID: 3883732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin.
    Arkonac BM; Kersten JR; Wynsen JC; Nijhawan N; Warltier DC
    Pharmacology; 1996 Feb; 52(2):92-100. PubMed ID: 8851630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic assessment in the medical treatment of acute myocardial infarction: the effects of various vasodilators and catecholamines.
    Hiroe M; Sekiguchi M; Hirosawa K; Shibata J
    Jpn Circ J; 1981 May; 45(5):591-22. PubMed ID: 6785502
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of nitroglycerin in acute myocardial infarction.
    Williams DO; Amsterdam EA; Mason DT
    Circulation; 1975 Mar; 51(3):421-7. PubMed ID: 806394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dihydroergotamine on hemodynamic molsidomine actions in anesthetized dogs.
    Fiedler VB; Göbel H; Nitz RE
    Can J Physiol Pharmacol; 1984 Jun; 62(6):634-9. PubMed ID: 6547632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.
    Tsujibayashi T; Niwa A; Taniguchi K; Takeuchi J
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):163-7. PubMed ID: 3865742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention with molsidomine of coronary artery spasm caused by alkalosis.
    Weber S; Kahan A; Pailleret JJ; Guérin F; Degeorges M
    Am Heart J; 1985 Mar; 109(3 Pt 2):704-7. PubMed ID: 3838408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.
    Martorana PA; Kettenbach B; Göbel H; Nitz RE
    Basic Res Cardiol; 1984; 79(5):503-12. PubMed ID: 6439183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic and myocardial effects of long-lasting venodilation in the conscious dog: analysis of molsidomine in comparison with nitrates.
    Holtz J; Bassenge E; Kolin A
    Basic Res Cardiol; 1978; 73(5):469-81. PubMed ID: 103534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Substituted sydnonimines: hemodynamic effects and distribution of coronary blood flow in normal and ischemic myocardium].
    Mosca SM; Gelpi RJ; Cingolani HE
    Acta Physiol Pharmacol Latinoam; 1985; 35(3):361-73. PubMed ID: 2938418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of nitroglycerin and molsidomine. Effects on the integrated systemic venous bed and the arterial pressure in dogs.
    Grund E; Müller-Ruchholtz ER; Lapp ER; Lösch HM; Lochner W
    Arzneimittelforschung; 1978; 28(9):1624-8. PubMed ID: 113018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.